Skip to main content

Radiological Investigations in Genitourinary Cancer

  • Chapter
Book cover Urological Oncology

Abstract

The intravenous urogram (IVU) forms part of the initial workup for patients with unexplained hematuria. With recent advances in computed tomography (CT) and magnetic resonance imaging (MRI) technology, the future of the IVU is a subject of ongoing debate (1), although at present it still remains integral to the diagnosis and surveillance of urothelial malignancy. It consists of a series of plain x-rays of the renal tract followed by intravenous administration of water-soluble, iodinated, contrast medium. The contrast medium is excreted by the kidneys, enabling visualization of high-density contrast-filled calyces, renal pelvis, ureters, and bladder. Tumors are demonstrated as filling defects (Fig. 3.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dalla PL. What is left of i.v. urography? Eur Radiol 2001;11(6):931–939.

    Article  Google Scholar 

  2. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999;72(859):701–703.

    CAS  PubMed  Google Scholar 

  3. Yousem DM, Gatewood OM, Goldman SM, Marshall FF. Synchronous and meta-chronous transitional cell carcinoma of the urinary tract: prevalence, incidence, and radiographic detection. Radiology 1988;167(3):613–618.

    CAS  PubMed  Google Scholar 

  4. Kang CH, Yu TJ, Hsieh HH, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 2003;98(8):1620–1626.

    Article  PubMed  Google Scholar 

  5. Joffe SA, Servaes S, Okon S, Horowitz M. Multi-detector row CT urography in the evaluation of hematuria. Radiographics 2003;23(6):1441–1455.

    Article  PubMed  Google Scholar 

  6. McNicholas MM, Raptopoulos VD, Schwartz RK, et al. Excretory phase CT urography for opacification of the urinary collecting system. AJR 1998;170:1261–1267.

    CAS  PubMed  Google Scholar 

  7. Caoili EM, Cohan RH, Korobkin M, et al. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology 2002;222(2):353–360.

    Article  PubMed  Google Scholar 

  8. Kawashima A, Glockner JF, King BF Jr. CT urography and MR urography. Radiol Clin North Am 2003;41(5):945–961.

    Article  PubMed  Google Scholar 

  9. Roy C, Tuchmann C, Morel M, et al. Is there still a place for angiography in the management of renal mass lesions? Eur Radiol 1999;9(2):329–335.

    Article  CAS  PubMed  Google Scholar 

  10. Lin PH, Terramani TT, Bush RL, et al. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma. J Vasc Surg 2003;38:446–450.

    Article  PubMed  Google Scholar 

  11. Wunderlich H, Schumann S, Jantitzky V, et al. Increase of renal cell carcinoma incidence in central Europe. Eur Urol 1998;33(6):538–541.

    Article  CAS  PubMed  Google Scholar 

  12. Lui KW, Gervais DA, Arellano RA, Mueller PR. Radiofrequency ablation of renal cell carcinoma. Clin Radiol 2003;58(12):905–913.

    Article  PubMed  Google Scholar 

  13. Zagoria RJ. Imaging-guided radiofrequency ablation of renal masses. Radiographics 2004;24(suppl 1):S59–S71.

    Article  PubMed  Google Scholar 

  14. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR 2000;174(2):323–331.

    CAS  PubMed  Google Scholar 

  15. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000;217(3):633–646.

    CAS  PubMed  Google Scholar 

  16. Pavlovich CP, Walther MM, Choyke PL, et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002;167(1):10–15.

    Article  PubMed  Google Scholar 

  17. Farrell MA, Charboneau WJ, DiMarco DS, et al. Imaging-guided radiofrequency ablation of solid renal tumors. AJR 2003;180(6):1509–1513.

    CAS  PubMed  Google Scholar 

  18. Veltri A, De Fazio G, Malfitana V, et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur Radiol 2004; 14:2303–2310.

    Article  PubMed  Google Scholar 

  19. Wah TM, Arellano RS, Gervais DA, et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005;237:1097–1102.

    Article  PubMed  Google Scholar 

  20. Thompson IM, Peek M. Improvement in survival of patients with renal cell carcinoma-the role of the serendipitously detected tumor. J Urol 1988;140(3):487–490.

    CAS  PubMed  Google Scholar 

  21. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001;166(5):1611–1623.

    Article  CAS  PubMed  Google Scholar 

  22. Bosniak MA. The current radiological approach to renal cysts. Radiology 1986; 158:1–10.

    CAS  PubMed  Google Scholar 

  23. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology 1991;179(2):307–317.

    CAS  PubMed  Google Scholar 

  24. Habboub HK, Abu-Yousef MM, Williams RD, et al. Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma. AJR 1997; 168(1):267–271.

    CAS  PubMed  Google Scholar 

  25. Kallman DA, King BF, Hattery RR, et al. Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography. J Comput Assist Tomogr 1992;16(2):240–247.

    Article  CAS  PubMed  Google Scholar 

  26. Robbin ML. Ultrasound contrast agents: a promising future. Radiol Clin North Am 2001;39:399–414.

    Article  CAS  PubMed  Google Scholar 

  27. Jakobsen JA. Ultrasound contrast agents: clinical applications. Eur Radiol 2001; 11(8):1329–1337.

    Article  CAS  PubMed  Google Scholar 

  28. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51(2):203–205.

    Article  CAS  PubMed  Google Scholar 

  29. Israel GM, Bosniak MA. Follow-up CT of moderately complex cystic lesions of the kidney (Bosniak category IIF). AJR 2003;181(3):627–633.

    PubMed  Google Scholar 

  30. Abecassis M, McLoughlin MJ, Langer B, Kudlow JE. Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg 1985;149(6):783–788.

    Article  CAS  PubMed  Google Scholar 

  31. Glazer HS, Weyman PJ, Sagel SS, et al. Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR 1982;139(1):81–85.

    CAS  PubMed  Google Scholar 

  32. Mitnick JS, Bosniak MA, Megibow AJ, Naidich DP. Non-functioning adrenal adenomas discovered incidentally on computed tomography. Radiology 1983;148: 495–499.

    CAS  PubMed  Google Scholar 

  33. Francis IR, Smid A, Gross MD, et al. Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 1988;166(2):353–356.

    CAS  PubMed  Google Scholar 

  34. Krestin GP, Freidmann G, Fishbach R, et al. Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. J Comput Assist Tomogr 1991; 15(1):104–110.

    Article  CAS  PubMed  Google Scholar 

  35. Frilling A, Tecklenborg K, Weber F, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004;136(6):1289–1296.

    Article  PubMed  Google Scholar 

  36. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996;200(3):743–747.

    CAS  PubMed  Google Scholar 

  37. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998;171:201–204.

    CAS  PubMed  Google Scholar 

  38. Korobkin M, Brodeur FJ, Francis IR, et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR 1998;170(3):747–752.

    CAS  PubMed  Google Scholar 

  39. Pena CS, Boland GW, Hahn PF, et al. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000;217(3):798–802.

    CAS  PubMed  Google Scholar 

  40. Johnson CD, Dunnick NR, Cohan RH, Illescas FF. Renal adenocarcinoma: CT staging of 100 tumors. AJR 1987;148(1):59–63.

    CAS  PubMed  Google Scholar 

  41. Fein AB, Lee JK, Balfe DM, et al. Diagnosis and staging of renal cell carcinoma: a comparison of MR imaging and CT. AJR 1987;148(4):749–753.

    CAS  PubMed  Google Scholar 

  42. Studer UE, Scherz S, Scheidegger J, et al. Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 1990;144 (2 pt 1):243–245.

    CAS  PubMed  Google Scholar 

  43. Clayman RV Jr, Gonzalez R, Fraley EE. Renal cancer invading the inferior vena cava: clinical review and anatomical approach. J Urol 1980;123(2):157–163.

    PubMed  Google Scholar 

  44. Hatcher PA, Anderson EE, Paulson DF, et al. Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 1991;145(1):20–23.

    CAS  PubMed  Google Scholar 

  45. Catalano C, Fraioli F, Laghi A, et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR 2003;180(5):1271–1277.

    CAS  PubMed  Google Scholar 

  46. MacVicar D. Staging of testicular germ cell tumours. Clin Radiol 1993;47:149–158.

    Article  CAS  PubMed  Google Scholar 

  47. Dixon AK, Ellis M, Sikora K. Computed tomography of testicular tumours: distribution of abdominal lymphadenopathy. Clin Radiol 1986;37(6):519–523.

    Article  CAS  PubMed  Google Scholar 

  48. Williams MP, Cook JV, Duchesne GM. Psoas nodes-an overlooked site of metastasis from testicular tumours. Clin Radiol 1989;40(6):607–609.

    Article  CAS  PubMed  Google Scholar 

  49. Coll DM, Uzzo RG, Herts BR, et al. 3-dimensional volume rendered computerized tomography for preoperative evaluation and intraoperative treatment of patients undergoing nephron sparing surgery. J Urol 1999;161(4):1097–1102.

    Article  CAS  PubMed  Google Scholar 

  50. Smith PA, Marshall FF, Corl FM, Fishman EK. Planning nephron-sparing renal surgery using 3D helical CT angiography. J Comput Assist Tomogr 1999;23(5): 649–654.

    Article  CAS  PubMed  Google Scholar 

  51. Coll DM, Herts BR, Davros WJ, Uzzo RG, Novick AC. Preoperative use of 3D volume rendering to demonstrate renal tumors and renal anatomy. Radiographics 2000; 20(2):431–438.

    CAS  PubMed  Google Scholar 

  52. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001;21(spec. No.):S237–S254.

    PubMed  Google Scholar 

  53. Mangar SA, Huddart RA, Parker CC, et al. Technological advances in radiotherapy for the treatment of localised prostate cancer. Eur J Cancer 2005;41(6):908–921.

    Article  PubMed  Google Scholar 

  54. Mallampati GK, Siegelman ES. MR imaging of the bladder. Magn Reson Imaging Clin North Am 2004;12:545–555.

    Article  Google Scholar 

  55. Rominger MB, Kenney PJ, Morgan DE, et al. Gadolinium-enhanced MR imaging of renal masses. Radiographics 1992;12(6):1097–1116.

    CAS  PubMed  Google Scholar 

  56. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995;197(2): 411–418.

    CAS  PubMed  Google Scholar 

  57. Heiken JP, Forman HP, Brown JJ. Neoplasms of the bladder, prostate, and testis. Radiol Clin North Am 1994;32(1):81–98.

    CAS  PubMed  Google Scholar 

  58. Claus FG, Hricak H, Hattery RR. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 2004;24(suppl 1):S167–S180.

    Article  PubMed  Google Scholar 

  59. Rajesh A, Coakley FV. MR imaging and MR spectroscopic imaging of prostate cancer. Magn Reson Imaging Clin North Am 2004;12(3):557–579.

    Article  Google Scholar 

  60. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195(2):385–390.

    CAS  PubMed  Google Scholar 

  61. Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002;224(3):701–706.

    Article  PubMed  Google Scholar 

  62. Huch Boni RA, Boner JA, Debatin JF, et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 1995;50(9): 593–600.

    Article  Google Scholar 

  63. Hull GW, Rabbani F, Abbas F, et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167 (2 pt 1):528–534.

    Article  PubMed  Google Scholar 

  64. Yu KK, Hricak H, Alagappan R, et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997;202(3):697–702.

    CAS  PubMed  Google Scholar 

  65. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology 1999;213(2):473–480.

    CAS  PubMed  Google Scholar 

  66. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213(2):481–488.

    CAS  PubMed  Google Scholar 

  67. Hricak H, Thoeni RF, Carroll PR, et al. Detection and staging of renal neoplasms: a reassessment of MR imaging. Radiology 1988;166(3):643–649.

    CAS  PubMed  Google Scholar 

  68. Aslam Sohaib SA, Teh J, Nargund VH, et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol 2002;167(3):1271–1275.

    Article  CAS  PubMed  Google Scholar 

  69. Myneni L, Hricak H, Carroll PR. Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol 1991;68(6):571–578.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Jacques, A.E.T., Reznek, R.H. (2008). Radiological Investigations in Genitourinary Cancer. In: Nargund, V.H., Raghavan, D., Sandler, H.M. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-1-84628-738-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-738-1_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-387-1

  • Online ISBN: 978-1-84628-738-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics